A newly-approved drug, Wegovy, has shown to have significant weight loss benefits. But it's unclear if insurers will cover the cost of the medication for the millions of Americans who might need it. Click here for article.
Wegovy, a newly-approved drug for obesity, has shown significant weight loss benefits, but its high cost raises questions about insurance coverage for many patients.
While some private insurers cover obesity drugs, it's uncertain if Wegovy will be included in their plans, with out-of-pocket costs reaching $1,000 to $1,500 per month.
Advocates emphasize the medical necessity of treating obesity and are pushing for insurance coverage and legislative changes to make medications like Wegovy more accessible to the millions of Americans struggling with obesity.
コメント